Upstream Bio Inc (UPB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.39 -0.57 (-6.36%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.39 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -62,806 | -20,537 |
| Depreciation Amortization | -1,566 | -1,200 |
| Accounts receivable | -515 | 314 |
| Accounts payable and accrued liabilities | 2,017 | 1,278 |
| Other Working Capital | 1,873 | -4,305 |
| Other Operating Activity | 1,825 | -13,476 |
| Operating Cash Flow | $-59,172 | $-37,926 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -58,974 | -82,698 |
| PPE Investments | -511 | -144 |
| Investing Cash Flow | $-59,485 | $-82,842 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 272,882 | 118 |
| Other Financing Activity | 146,028 | 129,432 |
| Financing Cash Flow | $418,910 | $129,550 |
| Beginning Cash Position | 25,833 | 17,051 |
| End Cash Position | 326,086 | 25,833 |
| Net Cash Flow | $300,253 | $8,782 |
| Free Cash Flow | ||
| Operating Cash Flow | -59,172 | -37,926 |
| Capital Expenditure | -511 | -144 |
| Free Cash Flow | -59,683 | -38,070 |